AT
Alloy Therapeutics
United States · Biotech · Healthtech · AI · Enterprise software
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
Discovery infrastructure for drug developers
Alloy Therapeutics supplies drug developers with discovery technology, laboratory services and development support. Partners can combine antibody and multispecific discovery, genetic-medicine platforms and pharmacology studies rather than building each capability internally.
Its workflow links computational modeling with experimental work to select and refine candidates. The wider organization includes 82VS, which builds asset-focused drug companies, and Spannerwerks, which supports programs progressing toward clinical development.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series E | $40M | 8VC — Role not disclosedAlexandria Venture Investments — Role not disclosedEcho Capital — Role not disclosedFounders Fund — Role not disclosedGaingels — Role not disclosedJIC Venture Growth Investments — Role not disclosedMubadala Capital — Role not disclosedPresight Capital — Role not disclosedThiel Capital — Role not disclosedUlysses Diversified Holdings — Role not disclosed |